title: The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families.
abstract: Calcium urolithiasis is often associated with increased intestinal absorption and urine excretion of calcium, and has been suggested to result from increased vitamin D production. The role of the enzyme 1 alpha-hydroxylase, the rate-limiting step in active vitamin D production, was evaluated in 36 families, including 28 sibships with at least a pair of affected sibs, using qualitative and quantitative trait linkage analyses. Sibs with a verified calcium urolithiasis passage (n = 117) had higher 24-h calciuria (P = 0.03), oxaluria (P = 0.02), fasting and postcalcium loading urine calcium/creatinine (Ca/cr) ratios (P = 0.008 and P = 0.002, respectively), and serum 1,25(OH)2 vitamin D levels (P = 0.02) compared with nonstone-forming sibs (n = 120). Markers from a 9-centiMorgan interval encompassing the VDD1 locus on chromosome 12q13-14 (putative 1 alpha-hydroxylase) were analyzed in 28 sibships (146 sib pairs) of single and recurrent stone formers and in 14 sibships (65 sib pairs) with recurrent-only (> or = 3 episodes) stone-forming sibs. Two-point and multipoint analyses did not reveal excess in alleles shared among affected sibs at the VDD1 locus. Linkage of stone formation to the VDD1 locus could be excluded, respectively, with a lambda d of 2.0 (single and recurrent stone formers) and 3.25 (recurrent stone formers). Quantitative trait analyses revealed no evidence for linkage to 24-h calciuria and oxaluria, serum 1,25(OH)2 vitamin D levels, and Ca/cr ratios. This study shows absence of linkage of the putative 1 alpha-hydroxylase locus to calcium stone formation or to quantitative traits associated with idiopathic hypercalciuria. In addition, there is coaggregation of calciuric and oxaluric phenotypes with stone formation.
authors.affiliation: Service de Néphrologie, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
authors.forename: P
authors.initials: P
authors.lastname: Scott
authors.forename: D
authors.initials: D
authors.lastname: Ouimet
authors.forename: Y
authors.initials: Y
authors.lastname: Proulx
authors.forename: M L
authors.initials: ML
authors.lastname: Trouvé
authors.forename: G
authors.initials: G
authors.lastname: Guay
authors.forename: B
authors.initials: B
authors.lastname: Gagnon
authors.forename: L
authors.initials: L
authors.lastname: Valiquette
authors.forename: A
authors.initials: A
authors.lastname: Bonnardeaux
mesh_terms: D015090:25-Hydroxyvitamin D3 1-alpha-Hydroxylase / Q000235:genetics* / Q000378:metabolism; D000328:Adult; D002118:Calcium / Q000652:urine*; D002170:Canada; D005192:Family Health; D005260:Female; D005602:France / Q000208:ethnology; D008040:Genetic Linkage; D005819:Genetic Markers / Q000235:genetics; D006801:Humans; D007669:Kidney Calculi / Q000201:enzymology* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D010375:Pedigree; D010641:Phenotype; D014807:Vitamin D / Q000097:blood; D044465:White People / Q000235:genetics*
chemical_list: D005819:Genetic Markers; D014807:Vitamin D; D015090:25-Hydroxyvitamin D3 1-alpha-Hydroxylase; D002118:Calcium